Halozyme Therapeutics (HALO) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Halozyme Therapeutics (HALO) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
67.94% |
| 10 |
Halozyme Therapeutics |
8.24 Bn |
7.92 Bn |
297.47 Mn |
7.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
7.10% |
| Dec 31, 2025 |
-148.93% |
| Sep 30, 2025 |
40.62% |
| Jun 30, 2025 |
77.79% |
| Mar 31, 2025 |
47.55% |
| Dec 31, 2024 |
99.72% |
| Sep 30, 2024 |
84.09% |
| Jun 30, 2024 |
23.29% |
| Mar 31, 2024 |
79.00% |
| Dec 31, 2023 |
18.72% |
| Sep 30, 2023 |
76.78% |
| Jun 30, 2023 |
91.55% |
| Mar 31, 2023 |
-72.47% |
| Dec 31, 2022 |
-40.74% |
| Sep 30, 2022 |
-74.28% |
| Jun 30, 2022 |
-79.34% |
| Mar 31, 2022 |
66.61% |
| Dec 31, 2021 |
78.48% |
| Sep 30, 2021 |
433.60% |
| Jun 30, 2021 |
799.20% |
